Analyzing Longitudinal wb-MRI Data and Clinical Course in a Cohort of Former Smoldering Multiple Myeloma Patients: Connections between MRI Findings and Clinical Progression Patterns
Authors:
- Markus WennmannMarkus Wennmann
- Thomas HielscherTHThomas Hielscher
- Laurent KintzeléLKLaurent Kintzelé
- Bjoern H. MenzeBMBjoern H. Menze
- Georg LangsGLGeorg Langs
- Maximilian MerzMMMaximilian Merz
- Sandra SauerSSSandra Sauer
- Hans-Ulrich KauczorHKHans-Ulrich Kauczor
- Heinz-Peter SchlemmerHSHeinz-Peter Schlemmer
- Stefan DelormeStefan Delorme
- Hartmut GoldschmidtHGHartmut Goldschmidt
- Niels WeinholdNWNiels Weinhold
Open Access
Abstract
The purpose of this study was to analyze size and growth dynamics of focal lesions (FL) as well as to quantify diffuse infiltration (DI) in untreated smoldering multiple myeloma (SMM) patients and correlate those MRI features with timepoint and cause of progression. We investigated 199 whole-body magnetic resonance imaging (wb-MRI) scans originating from longitudinal imaging of 60 SMM patients and 39 computed tomography (CT) scans for corresponding osteolytic lesions (OL) in 17 patients. All FLs >5 mm were manually segmented to quantify volume and growth dynamics, and DI was scored, rating four compartments separately in T1- and fat-saturated T2-weighted images. The majority of patients with at least two FLs showed substantial spatial heterogeneity in growth dynamics. The volume of the largest FL (p = 0.001, c-index 0.72), the speed of growth of the fastest growing FL (p = 0.003, c-index 0.75), the DI score (DIS, p = 0.014, c-index 0.67), and its dynamic over time (DIS dynamic, p < 0.001, c-index 0.67) all significantly correlated with the time to progression. Size and growth dynamics of FLs correlated significantly with presence/appearance of OL in CT within 2 years after the respective MRI assessment (p = 0.016 and p = 0.022). DIS correlated with decrease of hemoglobin (p < 0.001). In conclusion, size and growth dynamics of FLs correlate with prognosis and local bone destruction. Connections between MRI findings and progression patterns (fast growing FL—OL; DIS—hemoglobin decrease) might enable more precise diagnostic and therapeutic approaches for SMM patients in the future.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (WE 2709/3-1, ME 3511/3-1)
- Austrian Science Fund (I2714-B31)
- Dietmar Hopp Stiftung (1DH118373, 1DH1911364)
This publication has 45 references indexed in Scilit:
- Serum free light chain ratio as a biomarker for high-risk smoldering multiple myelomaLeukemia, 2012
- Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myelomaHaematologica, 2012
- Diagnosis of Smoldering Multiple MyelomaNew England Journal of Medicine, 2011
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight reviewLeukemia, 2009
- Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myelomaBlood, 2008
- Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple MyelomaNew England Journal of Medicine, 2007
- MR imaging of therapy-induced changes of bone marrowEuropean Radiology, 2006
- Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myelomaAnnals of Oncology, 2005
- Review of 1027 Patients With Newly Diagnosed Multiple MyelomaMayo Clinic Proceedings, 2003
- Bone marrow reconversion in adults who are smokers: MR Imaging findings.American Journal of Roentgenology, 1993